Gene Therapy Stops Bleeding in Hemophilia

(MedPage Today) -- A single injection of a viral-mediated gene therapy vector reduced the bleeding rate among patients with Factor IX-related hemophilia B by 91% over the course of 6 months, researchers reported.
In most cases, patients were able...